08/14/2024 7:29 AM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:21 PM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 8:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 6:26 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 5:53 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 5:57 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024 4:27 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/19/2024 4:30 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 4:12 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 6:07 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:41 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 4:37 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:57 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:38 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:58 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 5:56 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 6:11 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:46 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024 3:37 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:23 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:51 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:21 PM | ANI Pharmaceuticals (Issuer) Gutwerg Ori (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 6:34 AM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 5:08 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 3:35 PM | ANI Pharmaceuticals (Subject) CAREY STEPHEN P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024 6:54 PM | ANI Pharmaceuticals (Issuer) Leonard Matthew J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:58 PM | ANI Pharmaceuticals (Issuer) Pera Antonio R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:59 PM | ANI Pharmaceuticals (Issuer) TANNENBAUM RENEE P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 7:02 PM | ANI Pharmaceuticals (Issuer) Thoma Jeanne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 7:03 PM | ANI Pharmaceuticals (Issuer) Walsh Patrick D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:45 PM | ANI Pharmaceuticals (Issuer) HAUGHEY THOMAS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:14 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:21 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 5:01 PM | ANI Pharmaceuticals (Issuer) TANNENBAUM RENEE P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 5:05 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:50 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 4:02 PM | ANI Pharmaceuticals (Issuer) Lalwani Nikhil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 4:02 PM | ANI Pharmaceuticals (Subject) TANNENBAUM RENEE P (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 3:59 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024 6:47 PM | ANI Pharmaceuticals (Subject) Lalwani Nikhil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Fmr CIA Advisor reveals PEACEMAKER superweapon (Ad) Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9443&Placement=NativeDisplay&Source=NativeDisplay) Full details are in this announcement. |
05/13/2024 4:25 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 6:09 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024 5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2024 5:26 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 3:43 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024 3:50 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 3:33 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:19 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:41 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024 8:33 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024 5:28 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 8:12 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 8:13 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 8:53 PM | ANI Pharmaceuticals (Issuer) Rowland Thomas Andrew (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/05/2024 3:42 PM | ANI Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024 5:59 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 3:17 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 3:09 PM | ANI Pharmaceuticals (Issuer) Lalwani Nikhil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 6:30 AM | ANI Pharmaceuticals (Subject) Meridian Venture Partners II GP, L.P. (Filed by)
| Form SC 13D/A | |
03/13/2024 3:44 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:48 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 6:07 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 5:58 PM | ANI Pharmaceuticals (Subject) CAREY STEPHEN P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 5:39 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:43 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:25 PM | ANI Pharmaceuticals (Issuer) Lalwani Nikhil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | ANI Pharmaceuticals (Subject) Lalwani Nikhil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 8:42 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:21 PM | ANI Pharmaceuticals (Issuer) Gutwerg Ori (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:11 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:16 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:58 PM | ANI Pharmaceuticals (Subject) Lalwani Nikhil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 4:31 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:24 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:20 PM | ANI Pharmaceuticals (Issuer) Pera Antonio R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:18 PM | ANI Pharmaceuticals (Subject) Pera Antonio R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:09 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:12 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:18 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 3:55 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:22 AM | ANI Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 5:58 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2024 3:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:47 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:50 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:53 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:34 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:38 PM | ANI Pharmaceuticals (Issuer) Gutwerg Ori (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:26 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The $15 "Insider Secret" That Could Save Your Retirement (Ad) What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into?
That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9451&Placement=NativeDisplay&Source=NativeDisplay) Click here to discover the name and ticker of this "$15 billionaire-backed retirement stock" >>> |
02/13/2024 7:05 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 5:06 AM | ANI Pharmaceuticals (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024 7:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 5:14 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 4:32 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 3:52 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:30 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 5:20 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 4:06 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |